Table 1. Top 25 upregulated genes in PMT versus WT.
Agilent probe name | Gene name | Gene description | Gene ontology | Fold change | P-value |
---|---|---|---|---|---|
A_51_P358765 | Spp1 | Secreted phosphoprotein 1 or osteopontin | Antiapoptosis; biomineral formation; cell adhesion; ossification; osteoblast differentiation | 77.3 | 1.1 × 10−5 |
A_51_P301435 | B3galt5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase polypeptide 5 | Protein amino-acid glycosylation | 58.6 | 1.9 × 10−7 |
A_51_P384894 | Stfa1 | Stefin-A1-like protein | Cysteine-type endopeptidase inhibitor activity | 56.6 | 9.4 × 10−7 |
A_52_P6490 | Insr | Insulin receptor | Glucose homeostasis | 44.0 | 6.2 × 10−9 |
A_51_P409694 | Psrc1 | Differential display and activated by p53 | Cell cycle | 35.0 | 4.6 × 10−6 |
A_52_P646858 | Car12 | Carbonic anhydrase 12 | One-carbon metabolic process | 32.7 | 6.4 × 10−6 |
A_51_P256827 | S100a8 | S100 calcium-binding protein A8 (calgranulin A) | Chemotaxis; calcium-ion binding | 32.1 | 3.9 × 10−5 |
A_51_P240501 | 4930583H14 Rik | Ovary-specific acidic protein | Not determined | 30.1 | 5.1 × 10−4 |
A_51_P184484 | Mmp13 | Matrix metalloproteinase 13 | Metallopeptidase activity; bone mineralization; cartilage development | 25.5 | 3.9 × 10−5 |
A_52_P387009 | Egln3 | EGL nine homolog 3 | Apoptosis; cell proliferation; response to hypoxia | 22.7 | 1.2 × 10−6 |
A_51_P268154 | Acsl4 | Acyl-CoA synthetase long-chain family member 4 isoform 2 | Fatty-acid metabolism and transport | 20.5 | 2.3 × 10−9 |
A_52_P318673 | Saa1 | Serum amyloid A1 | Cholesterol metabolism | 20.2 | 6.5 × 10−5 |
A_51_P461040 | Crct1 | Cysteine-rich C-terminal 1 | Not determined | 20.0 | 1.8 × 10−4 |
A_52_P158095 | NAP107172-1 | Not determined | 19.3 | 4.1 × 10−5 | |
A_52_P232580 | Dyrk3 | Dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 3 | Erythrocyte differentiation; protein kinase activity | 18.8 | 1.7 × 10−6 |
A_52_P240232 | NAP052665-1 | Not determined | 18.6 | 1.8 × 10−5 | |
A_51_P499698 | Asprv1 | Aspartic peptidase, retroviral-like 1 | Proteolysis | 18.1 | 5.7 × 10−7 |
A_51_P302831 | Dbccr1 | Deleted in bladder cancer chromosome region candidate 1 | Cell cycle | 17.2 | 9.8 × 10−5 |
A_52_P59206 | Cst6 | Cystatin E/M | Epidermis development | 16.3 | 7.5 × 10−6 |
A_51_P459477 | Col11a1 | Procollagen, type XI, α1 | Cartilage development; cell adhesion; extracellular matrix constituent | 15.9 | 3.3 × 10−7 |
A_52_P220440 | Slc6a15 | Solute carrier family 6 (neurotransmitter transporter), member 15 | Neurotransmitter transport | 15.6 | 5.1 × 10−4 |
A_51_P457747 | Krt16 | Keratin 16 | Intermediate filament cytoskeleton organization | 15.0 | 4.2 × 10−5 |
A_51_P212782 | Il1b | Interleukin 1β | Inflammatory response; angiogenesis; insulin signaling; lipid metabolism; chemotaxis | 14.5 | 1.8 × 10−6 |
A_51_P147034 | Ica1l | Islet cell autoantigen 1-like | Not determined | 14.1 | 1.5 × 10−5 |
A_51_P491667 | Derl3 | Der1-like domain family, member 3 | Not determined | 14.1 | 5.6 × 10−6 |
Abbreviations: PMT, primary mammary tumor; WT, wild type.